uniQure (QURE) Net Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
uniQure (QURE) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -78,467.00 |
| 3 | Iovance Biotherapeutics | 3.80 Bn | 3.50 Bn | 55.72 Mn | 4.47 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 29,163.00 |
| 5 | uniQure | 3.04 Bn | 3.04 Bn | 5.49 Mn | 143,941.00 |
| 6 | Beam Therapeutics | 2.64 Bn | 2.64 Bn | - | -2.46 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 118,642.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 795.00 |
| 9 | Vericel | 1.98 Bn | 1.82 Bn | 56.40 Mn | 1,380.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,941.00 |
| Mar 31, 2026 | -5,268.00 |
| Dec 31, 2025 | 32,432.00 |
| Sep 30, 2025 | 112,689.00 |
| Jun 30, 2025 | 714,254.00 |
| Mar 31, 2025 | -17,995.00 |
| Dec 31, 2024 | -141,743.00 |
| Sep 30, 2024 | -10,379.00 |
| Jun 30, 2024 | -59,213.00 |
| Mar 31, 2024 | 837,996.00 |
| Dec 31, 2023 | -109,237.00 |
| Sep 30, 2023 | -336,023.00 |
| Jun 30, 2023 | -5,512.00 |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 158,476.00 |
| Sep 30, 2022 | -104,616.00 |
| Jun 30, 2022 | -659,020.00 |
| Mar 31, 2022 | -16,008.00 |
| Dec 31, 2021 | 137,542.00 |
| Sep 30, 2021 | -113,668.00 |